- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03500666
Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection
April 15, 2018 updated by: Bo Wang,MD, Fujian Medical University
A Comparative Study of Robot Assisted BABA Approach and Chest Breast Approach for Lateral Neck Dissection
Objective to compare the advantages and disadvantages of robotic and conventional endoscopic thyroidectomy for thyroid cancer.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
To compare the difference of operative time and complication between two operative methods in robot neck surgery and routine endoscopic surgery.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
FuZhou, Fujian, China, 350001
- Recruiting
- Fujian Medical University Union Hospital
-
Fuzhou, Fujian, China, 350001
- Recruiting
- Wen-xin ZHAO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- papillary thyroid carcinoma with clinically suspected or confirmed lateral lymph node metastasis;
- patient's concerns of neck scars and cosmetic requirement.
The exclusion criteria were as follows:
1) tumor size >4cm; 2) previous neck surgical history; 3)residual or recurrent tumors; 4) suspicious primary tumor or metastatic lymph node invasion of major vascular structures or recurrent laryngeal nerve.
5)metastatic lymph nodes occurred below the sternoclavicular joint.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Robot lateral neck lymph node dissection
Robot neck lateral lymph node dissection was performed in patients with thyroid cancer and lateral cervical lymph node metastasis.
|
Robot lateral neck lymph node dissection
Other Names:
|
|
EXPERIMENTAL: Total endoscopic lateral cervical lymph node dissection
Patients with thyroid cancer and lateral cervical lymph node metastases underwent total endoscopic neck dissection.
|
Total endoscopic lateral cervical lymph node dissection
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lateral cervical lymph node cleaning time
Time Frame: During surgery
|
Lateral cervical lymph node clean time from that beginning of cut the SCM leading edge to the end of the specimen
|
During surgery
|
|
Accessory nerve injury
Time Frame: During surgery
|
Accessory nerve injury
|
During surgery
|
|
Intraoperative internal jugular vein bleeding.
Time Frame: 6 months after surgery
|
Internal carotid vein hemorrhage affect that surgical procedure
|
6 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The time of the thyroid gland removal
Time Frame: During surgery
|
The time of the thyroid gland removal , including the opening of the white line to the thyroid, and the end of the specimen
|
During surgery
|
|
Number of participants with HypoParathyroidism
Time Frame: 6 months after surgery
|
The parathyroid function was examined six months after surgery.
|
6 months after surgery
|
|
Recurrent laryngeal nerve injury.
Time Frame: 6 months after surgery
|
The recurrent laryngeal nerve function due to nerve injury or thermal damage can not be recovered for 6 months.
|
6 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2018
Primary Completion (ANTICIPATED)
December 31, 2018
Study Completion (ANTICIPATED)
December 31, 2018
Study Registration Dates
First Submitted
April 2, 2018
First Submitted That Met QC Criteria
April 15, 2018
First Posted (ACTUAL)
April 18, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 18, 2018
Last Update Submitted That Met QC Criteria
April 15, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BND and RND
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Carcinoma
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMetastatic Differentiated Thyroid Gland Carcinoma | Refractory Differentiated Thyroid Gland Carcinoma | Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 | Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland... and other conditionsUnited States
-
National Cancer Institute (NCI)ExelixisCompletedRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Stage I Thyroid Gland Papillary Carcinoma | Stage II Thyroid Gland Papillary Carcinoma | Stage III Thyroid Gland Papillary Carcinoma | Tall Cell Variant Thyroid Gland Papillary Carcinoma | Stage I Thyroid Gland... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPoorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Squamous Cell Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8United States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedPoorly Differentiated Thyroid Gland Carcinoma | Recurrent Differentiated Thyroid Gland Carcinoma | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingPoorly Differentiated Thyroid Gland Carcinoma | Refractory Differentiated Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Tall Cell Variant Thyroid Gland Papillary Carcinoma | Differentiated Thyroid Gland Carcinoma | Thyroid... and other conditionsUnited States
-
Grupo Espanol de Tumores NeuroendocrinosMFARTerminatedMetastatic Thyroid Cancer | Metastatic Thyroid Papillary Carcinoma | Metastatic Thyroid Follicular CarcinomaSpain
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IVA Thyroid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Stage III Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPoorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVA Thyroid Gland...United States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IVA Thyroid Gland Papillary Carcinoma AJCC... and other conditionsUnited States
Clinical Trials on Robot
-
University of Maryland, BaltimoreTerminatedStroke Sequelae | HemiparesisUnited States
-
US Department of Veterans AffairsCompletedCerebrovascular Disorders | HemiplegiaUnited States
-
Children's Hospital Los AngelesUniversity of Southern CaliforniaCompleted
-
The Third Xiangya Hospital of Central South UniversityCompleted
-
Institut Paoli-CalmettesNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
National Rehabilitation Center, Seoul, KoreaUnknownStroke | Robot Assisted Gait TrainingKorea, Republic of
-
National Rehabilitation Center, Seoul, KoreaRecruitingStrokeKorea, Republic of
-
National Rehabilitation Center, Seoul, KoreaCompleted
-
University Hospital, GrenobleTIMC-IMAGCompletedMagnetic Resonance Imaging | Robotic Surgical ProceduresFrance